Who are Oncimmune's investors?

Oncimmune's investors include Balderton Capital, Seneca Partners.

Where is Oncimmune headquartered?

Oncimmune is headquartered in Dortmund, DE.

Oncimmune

Dortmund, DE · Founded 2006 · 33 employees on LinkedIn · 2 known investors

Find your way into Oncimmune

88 people in our graph share verified history with the Oncimmune team — schools, employers, funds. One of them is your warm intro.

Rohan Ozaunlockedknows Martin Gouldstone · together at University of Nottingham (overlapped)

knows the team · via University of Nottingham

knows the team · via Open Orphan Plc

knows the team · via Bielefeld University

×8knows the team · via Excelerate Health Ventures

Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.

AI & Machine Learning Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Martin Gouldstone inStrategic AdvisorMartin Gouldstone is a biotech executive and board chair. He currently chairs ValiRx, a publicly listed biotech company, and NCIMB, a microbial research organization, while serving as strategic advisor to Alden Scientific.

Petra Budde inChief Scientific OfficerShe has expertise in biomarker discovery and validation, protein array technologies, and autoantibody assays, with a focus on autoimmune diseases and cancer immunotherapy applications.

Hans-Dieter Zucht inChief Technical OfficerWith 25+ years in biomarker research and operations, he has authored over 50 scientific publications and contributed to EU-funded research in areas including proteomics, bioinformatics, and translational medicine.

James HeywoodCEO, Alden Scientific

Eva Maria JanerusPresident, Alden Scientific

Investors · 2

Balderton CapitalLondon · $5M – $50M

Seneca PartnersHaydock

Frequently asked questions

What does Oncimmune do?: Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.
Who are Oncimmune's investors?: Oncimmune's investors include Balderton Capital, Seneca Partners.
Where is Oncimmune headquartered?: Oncimmune is headquartered in Dortmund, DE.